{"id":"lovenox","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Bleeding","drugRate":"","severity":"common","organSystem":""},{"effect":"Anemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Thrombocytopenia","drugRate":"","severity":"common","organSystem":""},{"effect":"Elevation of serum aminotransferase","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Ecchymosis","drugRate":"","severity":"common","organSystem":""},{"effect":"Fever","drugRate":"","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Peripheral edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Confusion","drugRate":"","severity":"common","organSystem":""},{"effect":"Injection site pain","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Hemorrhage - Abdominal Surgery","drugRate":"4%","severity":"serious"},{"effect":"Hemorrhage - Colorectal Surgery","drugRate":"4%","severity":"serious"},{"effect":"Hemorrhage - Hip Replacement Surgery (without extended prophylaxis)","drugRate":"6%","severity":"serious"},{"effect":"Hemorrhage - Hip Replacement Surgery (peri-operative)","drugRate":"2%","severity":"serious"},{"effect":"Injection site hematomas (extended prophylaxis hip replacement)","drugRate":"9%","severity":"serious"},{"effect":"Intracranial hemorrhage","drugRate":"","severity":"serious"},{"effect":"Retroperitoneal hemorrhage","drugRate":"","severity":"serious"},{"effect":"Intraocular hemorrhage","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201476","moleculeType":"Oligosaccharide"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"3d263380-4f44-4fd8-aa2a-e69702ab258f","title":"LOVENOX (ENOXAPARIN SODIUM) INJECTION [CARDINAL HEALTH 107, LLC]"},"ecosystem":[],"mechanism":{"target":"Antithrombin-III"},"_scrapedAt":"2026-03-27T23:53:10.925Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Enoxaparin_sodium","title":"Enoxaparin sodium","extract":"Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication. It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis."},"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Deep venous thrombosis","diseaseId":"deep-venous-thrombosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myocardial infarction","diseaseId":"myocardial-infarction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of clot formation during haemodialysis","diseaseId":"prevention-of-clot-formation-during-haemodialysis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of venous thromboembolism","diseaseId":"prevention-of-venous-thromboembolism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary embolism","diseaseId":"pulmonary-embolism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Unstable angina","diseaseId":"unstable-angina","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07499037","phase":"PHASE2","title":"Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2027-01","conditions":"Pneumonia, Heart Failure","enrollment":200},{"nctId":"NCT05672550","phase":"PHASE4","title":"Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-28","conditions":"Pediatric Kidney Transplant Recipients","enrollment":50},{"nctId":"NCT07464808","phase":"NA","title":"Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-28","conditions":"Venous Thromboembolic Event","enrollment":25},{"nctId":"NCT06825416","phase":"PHASE3","title":"A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2025-03-16","conditions":"Prevention of Arterial and Venous Thrombosis","enrollment":1166},{"nctId":"NCT07462182","phase":"NA","title":"Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Aamir Latif","startDate":"2026-04-01","conditions":"Intrauterine Growth Restriction","enrollment":108},{"nctId":"NCT07015905","phase":"PHASE3","title":"REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-06-25","conditions":"Venous Thromboembolism (VTE)","enrollment":2000},{"nctId":"NCT06454630","phase":"PHASE2","title":"A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-06-27","conditions":"Venous Thromboembolism","enrollment":179},{"nctId":"NCT07437716","phase":"NA","title":"Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Laparascopic Sleeve Gastrectomy, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT07140211","phase":"PHASE3","title":"Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis","status":"RECRUITING","sponsor":"Marc Blondon","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum","enrollment":9200},{"nctId":"NCT07384598","phase":"NA","title":"Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.","status":"NOT_YET_RECRUITING","sponsor":"Clinique Saint Pierre Ottignies","startDate":"2026-02-01","conditions":"Thromboprophylaxis, Critical Illness, Intensive Care (ICU)","enrollment":60},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT06243510","phase":"NA","title":"Comparison of Apixaban Versus Enoxaparin","status":"ENROLLING_BY_INVITATION","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2023-11-24","conditions":"Bladder Cancer","enrollment":90},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT07124819","phase":"PHASE3","title":"Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin","status":"COMPLETED","sponsor":"Avexima Diol LLC","startDate":"2024-07-22","conditions":"Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE)","enrollment":215},{"nctId":"NCT07140523","phase":"PHASE2","title":"A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA","status":"RECRUITING","sponsor":"Sirius Therapeutics Co., Ltd.","startDate":"2025-09-16","conditions":"Venous Thromboembolism","enrollment":450},{"nctId":"NCT07330661","phase":"NA","title":"Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-01-01","conditions":"Deep Vein Thrombosis (DVT)","enrollment":1286},{"nctId":"NCT06370273","phase":"PHASE3","title":"Thromboprophylaxis in Lower Limb Immobilisation","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-11-12","conditions":"Thrombosis, Injury Leg","enrollment":10044},{"nctId":"NCT07270263","phase":"NA","title":"Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2024-11-22","conditions":"Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma","enrollment":100},{"nctId":"NCT05255003","phase":"PHASE4","title":"STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis","status":"RECRUITING","sponsor":"Tzu-Fei Wang","startDate":"2022-08-29","conditions":"Cancer-associated Thrombosis, Thrombocytopenia","enrollment":50},{"nctId":"NCT07243080","phase":"PHASE4","title":"Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention","status":"RECRUITING","sponsor":"Mayo Hospital Lahore","startDate":"2025-10-10","conditions":"Deep Venous Thromboses, Laparotomy Patients","enrollment":212},{"nctId":"NCT01588171","phase":"NA","title":"Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-05","conditions":"Venous Thromboembolic Diseases","enrollment":7020},{"nctId":"NCT05203705","phase":"PHASE2","title":"Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Shanghai Hengrui Pharmaceutical Co., Ltd.","startDate":"2022-03-07","conditions":"Prevention of Venous Thrombosis After TKA","enrollment":64},{"nctId":"NCT07228663","phase":"PHASE3","title":"Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-12-01","conditions":"Hip Fracture Surgery, Cardiovascular Prevention, Venous Thromboembolism (VTE)","enrollment":100},{"nctId":"NCT04861103","phase":"PHASE4","title":"Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-10-01","conditions":"Pregnancy, High Risk, Anticoagulants","enrollment":12},{"nctId":"NCT07213713","phase":"","title":"Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-10-01","conditions":"Venous Thromboembolism, Obese Patients","enrollment":80},{"nctId":"NCT07189897","phase":"PHASE4","title":"Apixaban or Enoxaparin After Head and Neck Cancer Surgery","status":"RECRUITING","sponsor":"Kiranya Arnold","startDate":"2025-10","conditions":"Venous Thromboembolism, Head and Neck Cancer","enrollment":76},{"nctId":"NCT03244020","phase":"PHASE4","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","status":"ENROLLING_BY_INVITATION","sponsor":"Massachusetts General Hospital","startDate":"2018-02-16","conditions":"Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma","enrollment":2868},{"nctId":"NCT06357403","phase":"","title":"Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-05-04","conditions":"Thrombosis, Pulmonary Embolism, Enoxaparin","enrollment":1300},{"nctId":"NCT06180889","phase":"PHASE2","title":"Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suzhou Alphamab Co., Ltd.","startDate":"2023-12-20","conditions":"Knee Arthroplasty, Total","enrollment":241},{"nctId":"NCT07168005","phase":"NA","title":"Informative Video Before LMWH Postpartum - Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum Care, Anxiety","enrollment":160},{"nctId":"NCT07165587","phase":"","title":"Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)","status":"COMPLETED","sponsor":"Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu","startDate":"2024-01-01","conditions":"Pelvic Fractures, Acetabular Fractures, Pelvic Trauma","enrollment":81},{"nctId":"NCT06517563","phase":"PHASE1","title":"Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin","status":"ACTIVE_NOT_RECRUITING","sponsor":"VarmX B.V.","startDate":"2024-08-14","conditions":"Coagulation Disorder","enrollment":16},{"nctId":"NCT06118957","phase":"PHASE2","title":"Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-10-11","conditions":"Thromboembolism","enrollment":64},{"nctId":"NCT05618808","phase":"PHASE2","title":"A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-05-24","conditions":"Venous Thromboembolism","enrollment":373},{"nctId":"NCT06913595","phase":"PHASE1","title":"Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-03-25","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07132515","phase":"PHASE4","title":"Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2023-08-15","conditions":"Cirrhosis, HCC - Hepatocellular Carcinoma, Portal Vein Thrombosis","enrollment":100},{"nctId":"NCT04762992","phase":"PHASE3","title":"LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)","status":"ENROLLING_BY_INVITATION","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2022-07-18","conditions":"Fetal Growth Retardation, Prematurity, Pre-Eclampsia","enrollment":12},{"nctId":"NCT07116239","phase":"NA","title":"Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-09","conditions":"Nephrotic Syndrome, Hypoalbuminemia","enrollment":60},{"nctId":"NCT06094699","phase":"NA","title":"Improving Sleep in the Neurology In-Patient Population","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-04-30","conditions":"Sleep","enrollment":145},{"nctId":"NCT06004674","phase":"PHASE2","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2023-12-26","conditions":"Adverse Pregnancy Outcome","enrollment":20},{"nctId":"NCT05226793","phase":"","title":"Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-11-17","conditions":"Venous Thromboembolism","enrollment":400},{"nctId":"NCT06220123","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2024-02-16","conditions":"Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery","enrollment":225},{"nctId":"NCT06515730","phase":"PHASE4","title":"Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-04-08","conditions":"Left Ventricular Thrombus, Acute Myocardial Infarction","enrollment":212},{"nctId":"NCT04504318","phase":"PHASE1, PHASE2","title":"Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT","status":"COMPLETED","sponsor":"Stanford University","startDate":"2020-08-12","conditions":"Venous Thromboembolism","enrollment":82},{"nctId":"NCT04997265","phase":"NA","title":"Strategies for Anticoagulation During Venovenous ECMO","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-12","conditions":"Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism","enrollment":26},{"nctId":"NCT04924322","phase":"PHASE2, PHASE3","title":"Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-05-11","conditions":"Deep Venous Thrombosis","enrollment":258},{"nctId":"NCT06868823","phase":"","title":"Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation","status":"RECRUITING","sponsor":"University Hospital, Motol","startDate":"2025-05-01","conditions":"Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO), Anticoagulants and Bleeding Disorders","enrollment":40},{"nctId":"NCT06114641","phase":"PHASE4","title":"Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2023-06-01","conditions":"Safety Issues, Effect of Drug","enrollment":220},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT05794165","phase":"PHASE2","title":"Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism","status":"ENROLLING_BY_INVITATION","sponsor":"Bryan Cotton","startDate":"2023-09-27","conditions":"Trauma Injury, Thromboembolism, Venous Thromboembolism","enrollment":314},{"nctId":"NCT05484557","phase":"NA","title":"Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury","status":"RECRUITING","sponsor":"Loewenstein Hospital","startDate":"2023-09-06","conditions":"Spinal Cord Injuries, Spinal Diseases","enrollment":60},{"nctId":"NCT06963320","phase":"PHASE2","title":"Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2025-01-20","conditions":"Circulatory Disease","enrollment":320},{"nctId":"NCT04536272","phase":"PHASE3","title":"Reduced Anticoagulation Targets in ECLS (RATE)","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2020-10-01","conditions":"Heart Failure, Respiratory Failure, Extracorporeal Membrane Oxygenation","enrollment":330},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT06689241","phase":"NA","title":"Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2024-10-01","conditions":"Morbid Obesity, Bariatric Surgery Candidate","enrollment":162},{"nctId":"NCT03891524","phase":"PHASE2","title":"A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-06-17","conditions":"Arthroplasty, Replacement, Knee","enrollment":1242},{"nctId":"NCT05895136","phase":"PHASE2","title":"A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).","status":"RECRUITING","sponsor":"European Foundation for Study of Chronic Liver Failure","startDate":"2024-07-01","conditions":"Liver Cirrhosis, Decompensated Cirrhosis of Liver, Acute on Chronic Liver Failure (ACLF)","enrollment":90},{"nctId":"NCT06494878","phase":"PHASE3","title":"The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-04","conditions":"Venous Thromboembolism, Postpartum Period, Aspirin","enrollment":8805},{"nctId":"NCT05058924","phase":"NA","title":"Low Molecular Weight hEparin vs. Aspirin Post-partum","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-08-29","conditions":"Venous Thromboembolism","enrollment":30},{"nctId":"NCT02798471","phase":"PHASE3","title":"Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-03-27","conditions":"Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)","enrollment":290},{"nctId":"NCT06010446","phase":"","title":"Intravenous Continuous LMWH Seems to Be Safe Alternative to UFH in VV ECMO Patients","status":"COMPLETED","sponsor":"University Hospital, Motol","startDate":"2019-05-15","conditions":"Refractory Respiratory Failure","enrollment":43},{"nctId":"NCT05245877","phase":"PHASE4","title":"Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2022-08-17","conditions":"Pancreas Cancer, Pancreas Neoplasm, Surgery","enrollment":800},{"nctId":"NCT04731558","phase":"PHASE4","title":"Pre- Vs Postoperative Thromboprophylaxis for Liver Resection","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2021-02-10","conditions":"Liver Cancer, Surgery, Thrombosis, Deep Vein","enrollment":1012},{"nctId":"NCT06818279","phase":"PHASE2, PHASE3","title":"Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-01-31","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":120},{"nctId":"NCT04362085","phase":"PHASE3","title":"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2020-05-11","conditions":"COVID-19","enrollment":465},{"nctId":"NCT06795698","phase":"PHASE2","title":"The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2019-03-01","conditions":"Fractures, Bone, CKD Stage 4, CKD Stage 3","enrollment":61},{"nctId":"NCT03532139","phase":"PHASE2","title":"Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2018-07-25","conditions":"Ovarian Cancer","enrollment":24},{"nctId":"NCT05752461","phase":"PHASE2","title":"SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2023-04-12","conditions":"Prevention of Venous Thromboembolism After Knee Arthroplasty","enrollment":353},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT04367831","phase":"PHASE4","title":"Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-05-02","conditions":"COVID-19, Venous Thromboses, Arterial Thrombosis","enrollment":94},{"nctId":"NCT04427098","phase":"PHASE2","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-05-22","conditions":"COVID-19","enrollment":301},{"nctId":"NCT05129800","phase":"","title":"Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2011-01-01","conditions":"Androgenetic Alopecia, Hair Loss, Alopecia","enrollment":72},{"nctId":"NCT04979780","phase":"","title":"Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-07-20","conditions":"Treatment of Venous Thromboembolism in Cancer Patients, Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients","enrollment":3708},{"nctId":"NCT05819112","phase":"","title":"A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness","status":"TERMINATED","sponsor":"Sanofi","startDate":"2023-04-25","conditions":"Venous Thromboembolism","enrollment":14799},{"nctId":"NCT01717573","phase":"NA","title":"Deferred Stent Trial in STEMI","status":"COMPLETED","sponsor":"NHS National Waiting Times Centre Board","startDate":"2012-03","conditions":"ST-Elevation Myocardial Infarction","enrollment":101},{"nctId":"NCT05819125","phase":"","title":"Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin","status":"TERMINATED","sponsor":"Sanofi","startDate":"2023-04-25","conditions":"Venous Thromboembolism","enrollment":21000},{"nctId":"NCT06442267","phase":"PHASE4","title":"Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-07-30","conditions":"Respiratory Insufficiency, Circulatory Failure, Thromboembolism","enrollment":90},{"nctId":"NCT06662240","phase":"NA","title":"Effect of Vibration Anesthesia on Pain, Ecchymosis and Comfort Level in Subcutaneous Heparin Injection","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2024-03-15","conditions":"Pain, Ecchymosis, Comfort","enrollment":142},{"nctId":"NCT06662253","phase":"PHASE2, PHASE3","title":"Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Alexandre Tran","startDate":"2025-01","conditions":"Venous Thromboembolism (VTE), Trauma Related Injuries","enrollment":150},{"nctId":"NCT06635317","phase":"PHASE4","title":"Efficacy of Aspirin in Preventing Venous Thromboembolism","status":"COMPLETED","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2022-04-24","conditions":"Venous Thromboembolism (VTE), Total Joint Arthroplasty, Total Hip Arthroplasty (THA)","enrollment":60},{"nctId":"NCT06585319","phase":"PHASE2, PHASE3","title":"Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19","status":"COMPLETED","sponsor":"Materno-Perinatal Hospital of the State of Mexico","startDate":"2020-02-01","conditions":"COVID 19","enrollment":36},{"nctId":"NCT00251576","phase":"PHASE3","title":"Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1999-11-01","conditions":"Acute Coronary Syndrome","enrollment":4497},{"nctId":"NCT01230658","phase":"","title":"Prophylactic Enoxaparin Dosing in Roux-en-Y Gastric Bypass Surgery Patients at St. Vincent Carmel","status":"COMPLETED","sponsor":"Ascension St. Vincent Carmel Hospital","startDate":"2010-01","conditions":"Obesity","enrollment":51},{"nctId":"NCT06531525","phase":"PHASE2","title":"Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-08-01","conditions":"Pregnancy Related, Protein S Deficiency","enrollment":48},{"nctId":"NCT04508855","phase":"","title":"Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)","status":"WITHDRAWN","sponsor":"AHEPA University Hospital","startDate":"2020-08-01","conditions":"Cancer, Atrial Fibrillation","enrollment":""},{"nctId":"NCT04164693","phase":"NA","title":"Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2019-01-01","conditions":"Thrombosis","enrollment":287},{"nctId":"NCT06416566","phase":"NA","title":"Low-Dose Enoxaparin in Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Zagazig University","startDate":"2024-05-15","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT04483960","phase":"PHASE3","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-07-28","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":2200},{"nctId":"NCT02984384","phase":"PHASE3","title":"PREVENTion of Clot in Orthopaedic Trauma","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2017-04-24","conditions":"Blood Clot, Trauma","enrollment":12424},{"nctId":"NCT06222216","phase":"NA","title":"The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults","status":"RECRUITING","sponsor":"TC Erciyes University","startDate":"2024-03-01","conditions":"Pain, Ecchymosis, A Randomized Controlled Trial","enrollment":60},{"nctId":"NCT05081375","phase":"PHASE4","title":"Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures","status":"TERMINATED","sponsor":"Valleywise Health","startDate":"2019-12-16","conditions":"Venous Thrombosis Deep (Limbs), Surgical Blood Loss","enrollment":6},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT02342444","phase":"PHASE4","title":"Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2014-02","conditions":"Trauma, Surgery, Deep Vein Thrombosis (DVT)","enrollment":606},{"nctId":"NCT06293287","phase":"PHASE2","title":"Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy","status":"UNKNOWN","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2024-01-31","conditions":"Radial Artery Occlusion","enrollment":156},{"nctId":"NCT06133803","phase":"PHASE4","title":"Lovenox With Aspirin in Thawed Blastocyst Transfer","status":"UNKNOWN","sponsor":"Fertility Center of Las Vegas","startDate":"2024-01-26","conditions":"Infertility, Female","enrollment":130},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT03339349","phase":"PHASE2","title":"Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma","status":"COMPLETED","sponsor":"University of Utah","startDate":"2017-11-15","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolus","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20130927","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20040518","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19980130","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20050307","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20230728","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20040723","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20001024","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20041020","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970506","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20020109","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20130906","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20001117","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20030620","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970527","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20030123","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000404","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19960315","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19991005","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20001214","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990303","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19950309","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20110413","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20181211","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970527","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19991005","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20170130","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19991108","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19981231","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20150803","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990420","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970516","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20080716","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20040421","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19980224","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20171026","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20131023","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20040413","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20070112","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20031218","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20130605","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19960626","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20020109","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20121128","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000620","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970307","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20211220","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20011130","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20001117","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19960130","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20030701","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20121206","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990928","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20010705","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000530","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990914","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20020109","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20121210","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20110420","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19940314","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20221201","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000127","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20091223","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990722","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19980327","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000602","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20090727","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20150824","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19990721","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20070516","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19970127","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19930329","type":"ORIG","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20140529","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"20000803","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"},{"date":"19961023","type":"SUPPL","sponsor":"SANOFI AVENTIS US","applicationNumber":"NDA020164"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":178,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Lovenox","genericName":"Lovenox","companyName":"University of Monastir","companyId":"university-of-monastir","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}